Table 1.
Baseline Demographic Variables for Medical Cannabis Patients and a Pilot Group of Treatment-As-Usual Patients
| Demographics | MC patients (n=37) n (%) or mean±SD | TAU patients (n=14) n (%) or mean±SD | Significance (two-tailed) |
|---|---|---|---|
| Gender identity | χ2=4.04, p=0.13, ϕ=0.28 | ||
| Female | 25 (67.6) | 11 (78.6) | |
| Male | 12 (32.4) | 2 (14.3) | |
| Nonbinary | 0 (0.0) | 1 (2.0) | |
| Age | 47.84±17.52 | 39.86±15.42 | F=2.24, p=0.14, η2=0.04 |
| Estimated IQ (WASI) | 121.68±7.60 | 118.57±14.50 | F=1.00, p=0.32, η2=0.02 |
| Race | χ2=6.44, p=0.17, ϕ=0.36 | ||
| White | 33 (89.2) | 10 (71.4) | |
| Asian | 2 (5.4) | 3 (21.4) | |
| Black | 2 (2.7) | 0 (0.0) | |
| Multiracial | 0 (0.0) | 1 (7.1) | |
| Other | 1 (2.7) | 0 (0.0) | |
| Past cannabis use | χ2=5.13, p=0.08, ϕ=0.32 | ||
| Cannabis naivea | 19 (51.4) | 12 (85.7) | |
| Past light useb | 12 (32.4) | 1 (7.1) | |
| Past frequent usec | 6 (16.2) | 1 (7.1) | |
| Cannabis abstinence (years)d | 23.89±16.16 | 43.50±2.12 | F=2.80, p=0.11, η2=0.14 |
a
Cannabis naive at baseline was defined as ≤15 lifetime uses and <1 use/month.
b
Past light cannabis use was defined as a previous period of ≥1 use/month and ≤2 uses/week.
c
Past frequent cannabis use was defined as a previous period of ≥3 uses/week.
d
Only patients with a history of past cannabis use reported years of abstinence.
MC, medical cannabis; TAU, treatment-as-usual; WASI, Wechsler Abbreviated Scale of Intelligence.